Eberhard Karls Universität Tübingen

Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer — Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany (2020) Schneeweiss A, Ettl J, Lüftner D, Beckmann M, Belleville E, Fasching P, Fehm TN, et al. Journal article Derivation of the 2d Gross–Pitaevskii Equation for Strongly Confined 3d Bosons (2020) Boßmann L Journal article Dihydropyrimidine Dehydrogenase Testing prior to Treatment with 5-Fluorouracil, Capecitabine, and Tegafur: A Consensus Paper (2020) Woermann B, Bokemeyer C, Burmeister T, Koehne CH, Schwab M, Arnold D, Blohmer JU, et al. Journal article, Review article Update Breast Cancer 2020 Part 3 - Early Breast Cancer (2020) Huober J, Schneeweiss A, Hartkopf AD, Müller V, Lux MP, Janni W, Ettl J, et al. Journal article, Review article Treatment landscape and prognosis after treatment with trastuzumab emtansine (2020) Laakmann E, Emons J, Taran FA, Janni W, Uhrig S, Overkamp F, Kolberg HC, et al. Journal article Update Breast Cancer 2020 Part 4 – Advanced Breast Cancer (2020) Tesch H, Müller V, Wöckel A, Ettl J, Belleville E, Schütz F, Hartkopf A, et al. Journal article, Review article Acute Kidney Allograft Injury Following Vitamin C Administration for Septic Shock (2020) Mahling M, Köppen M, Mühlbacher T, Amann KU, Königsrainer A, Heyne N, Häberle H, et al. Journal article Search for the eta mesic He-3 in the pd -> dp pi(0) reaction with the WASA-at-COSY facility (2020) Adlarson P, Augustyniak W, Bashkanov M, Bass SD, Bergmann FS, Berlowski M, Bondar A, et al. Journal article Cyclotron line energy in Hercules X-1: Stable after the decay (2020) Staubert R, Ducci L, Ji L, Fürst F, Wilms J, Rothschild RE, Pottschmidt K, et al. Journal article Progression-free survival and overall survival in patients with advanced her2-positive breast cancer treated with trastuzumab emtansine (T-dm1) after previous treatment with pertuzumab (2020) Michel LL, Hartkopf AD, Fasching P, Kolberg HC, Hadji P, Tesch H, Häberle L, et al. Journal article